1. Home
  2. IMNM vs BOSC Comparison

IMNM vs BOSC Comparison

Compare IMNM & BOSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • BOSC
  • Stock Information
  • Founded
  • IMNM 2006
  • BOSC 1990
  • Country
  • IMNM United States
  • BOSC Israel
  • Employees
  • IMNM N/A
  • BOSC N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • BOSC Computer Communications Equipment
  • Sector
  • IMNM Health Care
  • BOSC Telecommunications
  • Exchange
  • IMNM Nasdaq
  • BOSC Nasdaq
  • Market Cap
  • IMNM 747.7M
  • BOSC 19.7M
  • IPO Year
  • IMNM 2020
  • BOSC 1996
  • Fundamental
  • Price
  • IMNM $10.97
  • BOSC $3.27
  • Analyst Decision
  • IMNM Strong Buy
  • BOSC Strong Buy
  • Analyst Count
  • IMNM 5
  • BOSC 1
  • Target Price
  • IMNM $28.60
  • BOSC $5.00
  • AVG Volume (30 Days)
  • IMNM 874.7K
  • BOSC 26.9K
  • Earning Date
  • IMNM 11-13-2024
  • BOSC 11-27-2024
  • Dividend Yield
  • IMNM N/A
  • BOSC N/A
  • EPS Growth
  • IMNM N/A
  • BOSC 5.81
  • EPS
  • IMNM N/A
  • BOSC 0.38
  • Revenue
  • IMNM $10,129,000.00
  • BOSC $40,448,000.00
  • Revenue This Year
  • IMNM N/A
  • BOSC $6.20
  • Revenue Next Year
  • IMNM N/A
  • BOSC N/A
  • P/E Ratio
  • IMNM N/A
  • BOSC $8.61
  • Revenue Growth
  • IMNM N/A
  • BOSC N/A
  • 52 Week Low
  • IMNM $8.33
  • BOSC $2.50
  • 52 Week High
  • IMNM $30.96
  • BOSC $3.49
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 39.61
  • BOSC 48.68
  • Support Level
  • IMNM $10.76
  • BOSC $3.15
  • Resistance Level
  • IMNM $15.13
  • BOSC $3.49
  • Average True Range (ATR)
  • IMNM 0.98
  • BOSC 0.14
  • MACD
  • IMNM -0.29
  • BOSC -0.03
  • Stochastic Oscillator
  • IMNM 4.81
  • BOSC 35.29

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

Share on Social Networks: